Gluconeogenesis in moderately and severely hyperglycemic patients with type 2 diabetes mellitus.

We tested the generally accepted concept that increased gluconeogenesis (GNG) and endogenous glucose production (EGP) are the main reasons for postabsorptive hyperglycemia in patients with type 2 diabetes mellitus (T2DM). GNG was measured with the (2)H(2)O method by use of both the C5-to-C2 ratio (C5/C2, with gas chromatography-mass spectrometry) and the C5-to-(2)H(2)O ratio (C5/(2)H(2)O, with isotope ratio mass spectrometry), and EGP was measured with 3-[(3)H]glucose in 27 patients with T2DM [13 with fasting plasma glucose (FPG) >10 mM and 14 with FPG <10 mM] and in 7 weight- and age-matched nondiabetic controls. The results showed 1) that GNG could be determined accurately with (2)H(2)O by using either C5/C2 or C5/(2)H(2)O; 2) that whereas after an overnight fast of 16 h, GNG was higher in the entire group of patients with T2DM than in controls (6.4 vs. 5.0 micromol. kg(-1). min(-1) or 60.4 vs. 51.4% of EGP, P < 0.02), GNG was within normal limits (less than the mean +/- 2 SD of controls or <65.3%) in 11/14 (79%) patients with mild to moderate hyperglycemia (FPG <10 mM) and in 5/13 (38%) of patients with severe hyperglycemia (FPG 10-20 mM); 3) that elevated GNG in T2DM was associated with a 43% decrease in prehepatic insulin secretion, i.e., with hepatic insulin deficiency; and 4) that FPG correlated significantly with glucose clearance (insulin resistance) (r = 0.70) and with GNG (r = 0.50) or EGP (r = 0.45). We conclude 1) that peripheral insulin resistance is at least as important as GNG (and EGP) as a cause of postabsorptive hyperglycemia in T2DM and 2) that GNG and EGP in T2DM are increased under conditions of significant hepatic insulin deficiency and thus probably represent a late event in the course of T2DM.

[1]  B. Scribner A Critical Comment , 1976 .

[2]  S. Kalhan,et al.  Glucose turnover and gluconeogenesis in human pregnancy. , 1997, The Journal of clinical investigation.

[3]  E. Volpi,et al.  Evidence of Increased Systemic Glucose Production and Gluconeogenesis in an Early Stage of NIDDM , 1997, Diabetes.

[4]  R G Shulman,et al.  Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR. , 1991, Science.

[5]  R. Rizza,et al.  Effects of hepatic glycogen content on hepatic insulin action in humans: alteration in the relative contributions of glycogenolysis and gluconeogenesis to endogenous glucose production. , 1997, The Journal of clinical endocrinology and metabolism.

[6]  M. Stumvoll,et al.  Abnormal renal and hepatic glucose metabolism in type 2 diabetes mellitus. , 1998, The Journal of clinical investigation.

[7]  J. Wahren,et al.  Contributions of gluconeogenesis to glucose production in the fasted state. , 1996, The Journal of clinical investigation.

[8]  G. Boden,et al.  The effects of free fatty acids on gluconeogenesis and glycogenolysis in normal subjects. , 1999, The Journal of clinical investigation.

[9]  R. Steele,et al.  Measurement of size and turnover rate of body glucose pool by the isotope dilution method. , 1956, The American journal of physiology.

[10]  R. Shulman,et al.  Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study. , 1992, The Journal of clinical investigation.

[11]  J. Katz,et al.  Gluconeogenesis and the Cori cycle in 12-, 20-, and 40-h-fasted humans. , 1998, The American journal of physiology.

[12]  W. Sheu,et al.  Relationship Between Hepatic Glucose Production and Fasting Plasma Glucose Concentration in Patients With NIDDM , 1994, Diabetes.

[13]  R. Steele,et al.  Inhibition by infused glycerol of gluconeogenesis from other precursors. , 1971, The American journal of physiology.

[14]  K. M. Erickson,et al.  Prehepatic insulin production in man: kinetic analysis using peripheral connecting peptide behavior. , 1980, The Journal of clinical endocrinology and metabolism.

[15]  H G Hers,et al.  The control of glycogen metabolism in the liver. , 1976, Annual review of biochemistry.

[16]  J. Katz,et al.  Determination of gluconeogenesis in vivo with 14C-labeled substrates. , 1985, The American journal of physiology.

[17]  Bruce H. Frank,et al.  Use of biosynthetic human C-peptide in the measurement of insulin secretion rates in normal volunteers and type I diabetic patients. , 1986, The Journal of clinical investigation.

[18]  O. Owen,et al.  Effects of Therapy on the Nature and Quantity of Fuels Oxidized During Diabetic Ketoacidosis , 1980, Diabetes.

[19]  J. A. Scarlett,et al.  Receptor and postreceptor defects contribute to the insulin resistance in noninsulin-dependent diabetes mellitus. , 1981, The Journal of clinical investigation.

[20]  B V Howard,et al.  Relationships between insulin secretion, insulin action, and fasting plasma glucose concentration in nondiabetic and noninsulin-dependent diabetic subjects. , 1984, The Journal of clinical investigation.

[21]  J. Olefsky,et al.  In vivo kinetics of insulin action on peripheral glucose disposal and hepatic glucose output in normal and obese subjects. , 1986, The Journal of clinical investigation.

[22]  A. Consoli,et al.  Increased lipolysis and its consequences on gluconeogenesis in non-insulin-dependent diabetes mellitus. , 1992, The Journal of clinical investigation.

[23]  R. Sherwin,et al.  Hyperglycemia inhibits glucose production in man independent of changes in glucoregulatory hormones. , 1978, The Journal of clinical endocrinology and metabolism.

[24]  R. DeFronzo,et al.  Fasting hyperglycemia in non-insulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. , 1989, Metabolism: clinical and experimental.

[25]  S. Lillioja,et al.  Increased Rate of Cori Cycle in Obese Subjects With NIDDM and Effect of Weight Reduction , 1988, Diabetes.

[26]  Y. Patel,et al.  Phosphoenolpyruvate carboxykinase (GTP): the gene and the enzyme. , 1994, Advances in enzymology and related areas of molecular biology.

[27]  R. Hanson,et al.  Gluconeogenesis, its regulation in mammalian species , 1976 .

[28]  R. Wolfe,et al.  The relationship between gluconeogenic substrate supply and glucose production in humans. , 1990, The American journal of physiology.

[29]  H. Yki-Järvinen,et al.  Lipolysis and gluconeogenesis from glycerol are increased in patients with noninsulin-dependent diabetes mellitus. , 1992, The Journal of clinical endocrinology and metabolism.

[30]  K. Petersen,et al.  Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis. , 1999, American journal of physiology. Endocrinology and metabolism.

[31]  L. Mandarino,et al.  Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. , 1988, Metabolism: clinical and experimental.

[32]  A. Consoli,et al.  Mechanism of increased gluconeogenesis in noninsulin-dependent diabetes mellitus. Role of alterations in systemic, hepatic, and muscle lactate and alanine metabolism. , 1990, The Journal of clinical investigation.

[33]  M. West,et al.  Ultrastructural observations on renal glycogen in normal and pathologic human kidneys. , 1966, Laboratory investigation; a journal of technical methods and pathology.

[34]  B. Landau Stable isotope techniques for the study of gluconeogenesis in man. , 1997, Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme.

[35]  J. Katz,et al.  Glucose production, recycling, and gluconeogenesis in normals and diabetics: a mass isotopomer [U-13C]glucose study. , 1996, The American journal of physiology.

[36]  R. DeFronzo,et al.  Pathogenesis of NIDDM: A Balanced Overview , 1992, Diabetes Care.

[37]  S. Turner,et al.  Hepatic gluconeogenic fluxes and glycogen turnover during fasting in humans. A stable isotope study. , 1997, The Journal of clinical investigation.

[38]  G. Reaven,et al.  Relationship between plasma glucose and insulin concentration, glucose production, and glucose disposal in normal subjects and patients with non-insulin-dependent diabetes. , 1988, The Journal of clinical investigation.

[39]  O. Owen,et al.  In vivo and in vitro effects of antiinsulin receptor antibodies. , 1984, The Journal of clinical endocrinology and metabolism.